ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Non-invasive diagnosis"

  • 2021 American Transplant Congress

    Assessment of Donor-Derived Cell-Free DNA Performance Characteristics Across the Spectrum of TCMR and ABMR After Kidney Transplant

    L. Bu1, S. Anand2, A. Pai3, J. S. Bromberg4, T. Alhamad5, V. Bowers6, I. Moinuddin7, S. Ghosh8, W. Tian8, E. Stites9, G. Gupta7

    1University of Minnesota, Minneapolis, MN, 2Intermountain Medical Center, Murray, UT, 3University of Texas McGovern Medical School, Houston, TX, 4University of Maryland School of Medicine, Baltimore, MD, 5Washington University in St. Louis, St. Louis, MO, 6Tampa General Hospital, Tampa, FL, 7Virginia Commonwealth University, Richmond, VA, 8CareDx, Brisbane, CA, 9University of Colorado, Aurora, CO

    *Purpose: Different donor-derived cell-free DNA (dd-cfDNA) thresholds have been reported in association with varying TCMR, ABMR and “Borderline” diagnoses. Interpretation of dd-cfDNA levels spanning active…
  • 2021 American Transplant Congress

    Kidney Transplant Rejection Can Be Diagnosed or Even Predicted by Tracking Donor Reactive T Cell Clones in Post-transplant Samples

    Y. Sambandam1, M. Kandpal1, J. He1, X. Huang1, T. S. Taylor1, A. A. Shetty2, J. M. Mathew1, J. R. Leventhal1

    1Surgery-Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine, Nephrology Division, Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: To test if kidney transplant (KTx) rejection can be diagnosed by monitoring for donor reactive T-cell (DRTC) clones in post-transplant (post-tx) biopsy and non-invasively…
  • 2021 American Transplant Congress

    Donor-Derived Cell-Free DNA Levels Risk-Stratify Polyoma BK Viremia and Associated Clinical Events After Kidney Transplantation – Preliminary Results from ADMIRAL Study

    A. Pai1, L. Bu2, J. S. Bromberg3, G. Gupta4, I. Moinuddin4, T. Alhamad5, V. Bowers6, S. Ghosh7, W. Tian7, E. Stites8, S. Anand9

    1University of Texas McGovern Medical School, Houston, TX, 2University of Minnesota, Minneapolis, MN, 3University of Maryland School of Medicine, Baltimore, MD, 4Virginia Commonwealth University, Richmond, VA, 5Washington University in St. Louis, St. Louis, MO, 6Tampa General Hospital, Tampa, FL, 7CareDx, Brisbane, CA, 8University of Colorado, Aurora, CO, 9Intermountain Medical Center, Murray, UT

    *Purpose: The threshold of 10,000 copies for blood Quant BK PCR has been used as a surrogate for BK nephropathy (BKN) in kidney transplant recipients…
  • 2021 American Transplant Congress

    High Donor-Derived Cell-Free DNA Levels Predict Development of De Novo HLA Donor-Specific Antibodies After Kidney Transplantation – Data from the ADMIRAL Study

    G. Gupta1, T. Alhamad2, V. Bowers3, I. Moinuddin1, S. Ghosh4, J. Zeng4, E. Stites5, A. Pai6, J. S. Bromberg7, S. Anand8

    1Virginia Commonwealth University, Richmond, VA, 2Washington University in St. Louis, St. Louis, MO, 3Tampa General Hospital, Tampa, FL, 4CareDx, Brisbane, CA, 5University of Colorado, Aurora, CO, 6University of Texas McGovern Medical School, Houston, TX, 7University of Maryland School of Medicine, Baltimore, MD, 8Intermountain Medical Center, Murray, UT

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) as a marker of injury can serve to quantify subclinical inflammation and molecular injury. As the release of graft genomic…
  • 2021 American Transplant Congress

    Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Monitoring Antibody-mediated Rejection After Kidney Transplantation

    M. Kim, S. Lim, S. Shin

    Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

    *Purpose: This study aims to discover and validate urinary exosomal biomarkers for antibody-mediated rejection (ABMR) after kidney transplantation.*Methods: A total of 60 urine samples from…
  • 2020 American Transplant Congress

    Integrated Multicohort Analysis of Transcriptome Profiles Identifies Blood Gene Signature to Distinguish Rejection from Infection in Patients with Solid Organ Transplants

    L. C. Murphy, A. Rao, M. Donato, P. Khatri

    School of Medicine, Stanford University, Stanford, CA

    *Purpose: Allograft rejection and infection are now leading causes of morbidity and mortality in transplant recipients. Current diagnosis relies on nonspecific markers of graft injury,…
  • 2020 American Transplant Congress

    Assessment of the Usefulness of Urine Signature to Differentiate Acute Rejection in a Prospective Kidney Transplantation Cohort

    J. Seo1, S. Jung2, J. Moon2, K. Jeong3, C. Kim4, B. Chung5, J. Park6, Y. Kim7, S. Lee2

    1Department of Core Research Laboratory, Medical Science Institute, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 2Department of Internal Medicine, Division of Nephrology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 3Department of Internal Medicine, Division of Nephrology, College of Medicine, Kyung Hee University, Seoul, Korea, Republic of, 4Department of Internal Medicine, Division of Nephrology, Kyung-pook National University School of Medicine, Daegu, Korea, Republic of, 5Department of Internal Medicine, Division of Nephrology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, 6Department of Internal Medicine, Sungkyunkwan University, Samsung Hospital, College of Medicine, Seoul, Korea, Republic of, 7Department of Internal Medicine, Division of Nephrology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea, Republic of

    *Purpose: Despite many biomarker studies in the field of transplantation, development and validation of noninvasive molecular assays to diagnose disease and monitor immune activity is…
  • 2020 American Transplant Congress

    Calibration of Donor-Derived Cell-Free DNA Criteria for Rejection with Molecular Diagnoses of Kidney Transplant Biopsies

    I. Moinuddin1, D. Kumar1, L. Kamal1, A. King1, L. Kang1, M. Levy1, S. Bobba1, D. Massey1, P. Halloran2, G. Gupta1

    1Virginia Commonwealth University, Richmond, VA, 2Alberta Transplant Genomics Applied Centre, Edmonton, AB, Canada

    *Purpose: Traditional microscopic histopathologic assessment (HDx) can be prone to error due to inter-observer variability as well as the non-specificity of some histologic lesions. Donor-derived…
  • 2020 American Transplant Congress

    Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria

    G. Huang1, X. Chen1, W. Chen1, P. Chen1, T. Jiang2, C. Wang1, L. Chen1

    1The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2AlloDx Biotech Co., Ltd, Suzhou, China

    *Purpose: BK polyomavirus nephropathy (BKVN) are important cause of dysfunction and failure of renal transplants, which is similar to T cell mediated rejection (TCMR) in…
  • 2020 American Transplant Congress

    Non-Invasive Near Infrared Fluorescence Based Monitoring of Macrophage Mediated Inflammation

    H. Karagoz1, N. Vettikattu1, F. Selek1, H. Kapucu1, E. Goktas1, L. Liu2, Y. Kulahci1, F. Zor1, J. M. Janjic2, V. S. Gorantla1

    1Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, 2Department of Pharmaceuticals, Duquesne University, Pittsburgh, PA

    *Purpose: Clinical assessments for inflammation and acute rejection (AR) require regular, invasive biopsies followed by staining protocols that provide static images of tissue. Despite such…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences